{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:52:36Z","timestamp":1793400756775,"version":"4.5.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["P2GEP3_178155"],"award-info":[{"award-number":["P2GEP3_178155"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00134-019-05862-0","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T02:02:37Z","timestamp":1574733757000},"page":"202-214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Missed vaccinations and critical care admission: all you may wish to know or rediscover\u2014a narrative review"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2395-4574","authenticated-orcid":false,"given":"Laure F.","family":"Pittet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7265-1887","authenticated-orcid":false,"given":"Mohamed","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7984-8669","authenticated-orcid":false,"given":"Claire-Anne","family":"Siegrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3667-7131","authenticated-orcid":false,"given":"Didier","family":"Pittet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"5862_CR1","first-page":"1","volume-title":"Plotkin\u2019s vaccines","author":"SL Plotkin","year":"2018","unstructured":"Plotkin SL, Plotkin SA (2018) A short history of vaccination. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM (eds) Plotkin\u2019s vaccines. Elsevier, Philadelphia, pp 1\u201315"},{"key":"5862_CR2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s00134-011-2235-z","volume":"37","author":"L Reisner-Senelar","year":"2011","unstructured":"Reisner-Senelar L (2011) The birth of intensive care medicine: Bjorn Ibsen\u2019s records. Intensive Care Med 37:1084\u20131086","journal-title":"Intensive Care Med"},{"key":"5862_CR3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.15585\/mmwr.mm6833a4","volume":"68","author":"M Martinez","year":"2019","unstructured":"Martinez M, Shukla H, Nikulin J, Mbaeyi C, Jorba J, Ehrhardt D (2019) Progress toward poliomyelitis eradication\u2014Afghanistan, January 2018\u2013May 2019. MMWR Morb Mortal Wkly Rep 68:729\u2013733","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5862_CR4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12889-017-4111-4","volume":"17","author":"HH Kyu","year":"2017","unstructured":"Kyu HH, Mumford JE, Stanaway JD, Barber RM, Hancock JR, Vos T, Murray CJ, Naghavi M (2017) Mortality from tetanus between 1990 and 2015: findings from the global burden of disease study 2015. BMC Public Health 17:179","journal-title":"BMC Public Health"},{"key":"5862_CR5","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.15585\/mmwr.mm6745a2","volume":"67","author":"K VanderEnde","year":"2018","unstructured":"VanderEnde K, Gacic-Dobo M, Diallo MS, Conklin LM, Wallace AS (2018) Global routine vaccination coverage\u20142017. MMWR Morb Mortal Wkly Rep 67:1261\u20131264","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5862_CR6","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1097\/CCM.0000000000000545","volume":"42","author":"JR Ortiz","year":"2014","unstructured":"Ortiz JR, Neuzil KM, Shay DK, Rue TC, Neradilek MB, Zhou H, Seymour CW, Hooper LG, Cheng PY, Goss CH, Cooke CR (2014) The burden of influenza-associated critical illness hospitalizations. Crit Care Med 42:2325\u20132332","journal-title":"Crit Care Med"},{"key":"5862_CR7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/INF.0b013e31818a65d2","volume":"28","author":"QL Zhang","year":"2009","unstructured":"Zhang QL, Wan CM, MacDonald NE (2009) Vaccine preventable infections and multiple organ dysfunction syndrome in critically ill children in China. Pediatr Infect Dis J 28:182\u2013185","journal-title":"Pediatr Infect Dis J"},{"key":"5862_CR8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1542\/peds.2013-0698","volume":"133","author":"F Zhou","year":"2014","unstructured":"Zhou F, Shefer A, Wenger J, Messonnier M, Wang LY, Lopez A, Moore M, Murphy TV, Cortese M, Rodewald L (2014) Economic evaluation of the routine childhood immunization program in the United States, 2009. Pediatrics 133:577\u2013585","journal-title":"Pediatrics"},{"key":"5862_CR9","doi-asserted-by":"crossref","first-page":"8131","DOI":"10.1016\/j.vaccine.2018.10.005","volume":"36","author":"W Yu","year":"2018","unstructured":"Yu W, Lee LA, Liu Y, Scherpbier RW, Wen N, Zhang G, Zhu X, Ning G, Wang F, Li Y, Hao L, Zhang X, Wang H (2018) Vaccine-preventable disease control in the People\u2019s Republic of China: 1949\u20132016. Vaccine 36:8131\u20138137","journal-title":"Vaccine"},{"key":"5862_CR10","volume-title":"The Cutter incident: how America\u2019s first polio vaccine led to the growing vaccine crisis","author":"PA Offit","year":"2005","unstructured":"Offit PA (2005) The Cutter incident: how America\u2019s first polio vaccine led to the growing vaccine crisis. Yale University Press, New Haven"},{"key":"5862_CR11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(97)11096-0","volume":"351","author":"AJ Wakefield","year":"1998","unstructured":"Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA (1998) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351:637\u2013641","journal-title":"Lancet"},{"key":"5862_CR12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jhin.2018.08.001","volume":"100","author":"A Peters","year":"2018","unstructured":"Peters A, Tartari E, Lotfinejad N, Parneix P, Pittet D (2018) Fighting the good fight: the fallout of fake news in infection prevention and why context matters. J Hosp Infect 100:365\u2013370","journal-title":"J Hosp Infect"},{"key":"5862_CR13","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.clinthera.2017.07.003","volume":"39","author":"CC McClure","year":"2017","unstructured":"McClure CC, Cataldi JR, O\u2019Leary ST (2017) Vaccine hesitancy: where we are and where we are going. Clin Ther 39:1550\u20131562","journal-title":"Clin Ther"},{"key":"5862_CR14","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(09)61203-4","volume":"374","author":"JP Watt","year":"2009","unstructured":"Watt JP, Wolfson LJ, O\u2019Brien KL, Henkle E, Deloria-Knoll M, McCall N, Lee E, Levine OS, Hajjeh R, Mulholland K, Cherian T (2009) Burden of disease caused by Haemophilus influenzae type b in children younger than 5\u00a0years: global estimates. Lancet 374:903\u2013911","journal-title":"Lancet"},{"key":"5862_CR15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-323-35761-6.00023-7","volume-title":"Plotkin\u2019s vaccines","author":"SA Nanduri","year":"2018","unstructured":"Nanduri SA, Sutherland AR, Gordon LK, Santosham M (2018) Haemophilus influenzae type b vaccines. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM (eds) Plotkin\u2019s vaccines. Elsevier, Philadelphia, pp 301\u2013318"},{"key":"5862_CR16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.13.2.302","volume":"13","author":"H Peltola","year":"2000","unstructured":"Peltola H (2000) Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25\u00a0years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 13:302\u2013317","journal-title":"Clin Microbiol Rev"},{"key":"5862_CR17","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/j.vaccine.2010.07.028","volume":"28","author":"RA Hajjeh","year":"2010","unstructured":"Hajjeh RA, Privor-Dumm L, Edmond K, O\u2019Loughlin R, Shetty S, Griffiths UK, Bear AP, Cohen AL, Chandran A, Schuchat A, Mulholland EK, Santosham M (2010) Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience. Vaccine 28:7123\u20137129","journal-title":"Vaccine"},{"key":"5862_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","volume":"67","author":"T Welte","year":"2012","unstructured":"Welte T, Torres A, Nathwani D (2012) Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 67:71\u201379","journal-title":"Thorax"},{"issue":"Suppl 5","key":"5862_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/1469-0691.12461","volume":"20","author":"JJ Drijkoningen","year":"2014","unstructured":"Drijkoningen JJ, Rohde GG (2014) Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect 20(Suppl 5):45\u201351","journal-title":"Clin Microbiol Infect"},{"key":"5862_CR20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/jech-2011-200168","volume":"66","author":"CJ Wotton","year":"2012","unstructured":"Wotton CJ, Goldacre MJ (2012) Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses. J Epidemiol Community Health 66:1177\u20131181","journal-title":"J Epidemiol Community Health"},{"key":"5862_CR21","doi-asserted-by":"crossref","first-page":"ofu024","DOI":"10.1093\/ofid\/ofu024","volume":"1","author":"KM Shea","year":"2014","unstructured":"Shea KM, Edelsberg J, Weycker D, Farkouh RA, Strutton DR, Pelton SI (2014) Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis 1:ofu024","journal-title":"Open Forum Infect Dis"},{"key":"5862_CR22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1469-0691.2009.02918.x","volume":"15","author":"C Garcia-Vidal","year":"2009","unstructured":"Garcia-Vidal C, Carratala J, Fernandez-Sabe N, Dorca J, Verdaguer R, Manresa F, Gudiol F (2009) Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin Microbiol Infect 15:1033\u20131038","journal-title":"Clin Microbiol Infect"},{"key":"5862_CR23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jinf.2016.01.011","volume":"72","author":"I Grau","year":"2016","unstructured":"Grau I, Ardanuy C, Cubero M, Benitez MA, Linares J, Pallares R (2016) Declining mortality from adult pneumococcal infections linked to children\u2019s vaccination. J Infect 72:439\u2013449","journal-title":"J Infect"},{"key":"5862_CR24","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/CMR.00024-15","volume":"28","author":"KA Geno","year":"2015","unstructured":"Geno KA, Gilbert GL, Song JY, Skovsted IC, Klugman KP, Jones C, Konradsen HB, Nahm MH (2015) Pneumococcal capsules and their types: past, present, and future. Clin Microbiol Rev 28:871\u2013899","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 5","key":"5862_CR25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2012.03938.x","volume":"18","author":"LF Pittet","year":"2012","unstructured":"Pittet LF, Posfay-Barbe KM (2012) Pneumococcal vaccines for children: a global public health priority. Clin Microbiol Infect 18(Suppl 5):25\u201336","journal-title":"Clin Microbiol Infect"},{"key":"5862_CR26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/QCO.0b013e3283531b0f","volume":"25","author":"R Borrow","year":"2012","unstructured":"Borrow R, Heath PT, Siegrist CA (2012) Use of pneumococcal polysaccharide vaccine in children: what is the evidence? Curr Opin Infect Dis 25:292\u2013303","journal-title":"Curr Opin Infect Dis"},{"key":"5862_CR27","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1016\/j.vaccine.2013.04.085","volume":"31","author":"LA Jackson","year":"2013","unstructured":"Jackson LA, Gurtman A, van Cleeff M, Jansen KU, Jayawardene D, Devlin C, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B (2013) Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults. Vaccine 31:3577\u20133584","journal-title":"Vaccine"},{"key":"5862_CR28","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/j.vaccine.2007.06.004","volume":"25","author":"DA Scott","year":"2007","unstructured":"Scott DA, Komjathy SF, Hu BT, Baker S, Supan LA, Monahan CA, Gruber W, Siber GR, Lockhart SP (2007) Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults. Vaccine 25:6164\u20136166","journal-title":"Vaccine"},{"issue":"Suppl 4","key":"5862_CR29","doi-asserted-by":"crossref","first-page":"D60","DOI":"10.1016\/j.vaccine.2015.05.102","volume":"33","author":"T Pilishvili","year":"2015","unstructured":"Pilishvili T, Bennett NM (2015) Pneumococcal disease prevention among adults: strategies for the use of pneumococcal vaccines. Vaccine 33(Suppl 4):D60\u2013D65","journal-title":"Vaccine"},{"key":"5862_CR30","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.14309\/ajg.0000000000000289","volume":"114","author":"LF Pittet","year":"2019","unstructured":"Pittet LF, Verolet CM, Michetti P, Girardin M, Juillerat P, Mottet C, Maillard MH, Siegrist CA, Posfay-Barbe KM, Swiss Inflammatory Bowel Disease Cohort Study Group (2019) High immunogenicity of the pneumococcal conjugated vaccine in immunocompromised adults with inflammatory bowel disease. Am J Gastroenterol 114:1130\u20131141","journal-title":"Am J Gastroenterol"},{"key":"5862_CR31","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","volume":"372","author":"MJ Bonten","year":"2015","unstructured":"Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, van Werkhoven CH, van Deursen AM, Sanders EA, Verheij TJ, Patton M, McDonough A, Moradoghli-Haftvani A, Smith H, Mellelieu T, Pride MW, Crowther G, Schmoele-Thoma B, Scott DA, Jansen KU, Lobatto R, Oosterman B, Visser N, Caspers E, Smorenburg A, Emini EA, Gruber WC, Grobbee DE (2015) Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 372:1114\u20131125","journal-title":"N Engl J Med"},{"key":"5862_CR32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s12325-014-0157-1","volume":"31","author":"P Castiglia","year":"2014","unstructured":"Castiglia P (2014) Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe. Adv Ther 31:1011\u20131044","journal-title":"Adv Ther"},{"key":"5862_CR33","first-page":"91","volume":"64","author":"DK Kim","year":"2015","unstructured":"Kim DK, Bridges CB, Harriman KH (2015) Advisory committee on immunization practices recommended immunization schedule for adults aged 19\u00a0years or older\u2014United States, 2015. MMWR Morb Mortal Wkly Rep 64:91\u201392","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5862_CR34","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/B978-0-323-35761-6.00063-8","volume-title":"Plotkin\u2019s vaccines","author":"JE Staples","year":"2018","unstructured":"Staples JE, Monath TP, Gershman MD, Barrett ADT (2018) Yellow fever vaccines. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM (eds) Plotkin\u2019s vaccines. Elsevier, Philadelphia, pp 1181\u20131265"},{"key":"5862_CR35","volume-title":"A global strategy to eliminate yellow fever epidemics 2017\u20132026","author":"World Health Organization","year":"2018","unstructured":"World Health Organization (2018) A global strategy to eliminate yellow fever epidemics 2017\u20132026. World Health Organization, Geneva"},{"key":"5862_CR36","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJMoa1710430","volume":"381","author":"RM Casey","year":"2018","unstructured":"Casey RM, Harris JB, Ahuka-Mundeke S, Dixon MG, Kizito GM, Nsele PM, Umutesi G, Laven J, Kosoy O, Paluku G, Gueye AS, Hyde TB, Ewetola R, Sheria GKM, Muyembe-Tamfum J-J, Staples JE (2018) Immunogenicity of fractional-dose vaccine during a yellow fever outbreak\u2014final report. N Engl J Med 381:444\u2013454","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"5862_CR37","doi-asserted-by":"crossref","first-page":"B26","DOI":"10.1016\/j.vaccine.2011.12.032","volume":"30","author":"SA Halperin","year":"2012","unstructured":"Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, Ladhani SN, McIntyre P, Ramsay ME, Safadi MA (2012) The changing and dynamic epidemiology of meningococcal disease. Vaccine 30(Suppl 2):B26\u2013B36","journal-title":"Vaccine"},{"key":"5862_CR38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","volume":"357","author":"ME Ramsay","year":"2001","unstructured":"Ramsay ME, Andrews N, Kaczmarski EB, Miller E (2001) Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 357:195\u2013196","journal-title":"Lancet"},{"key":"5862_CR39","unstructured":"World Health Organization (2019) Immunization. https:\/\/www.who.int\/news-room\/facts-in-pictures\/detail\/immunization. Accessed 8 Aug 2019"},{"key":"5862_CR40","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/21645515.2017.1412020","volume":"14","author":"MM Mustapha","year":"2018","unstructured":"Mustapha MM, Harrison LH (2018) Vaccine prevention of meningococcal disease in Africa: major advances, remaining challenges. Hum Vaccines Immunother 14:1107\u20131115","journal-title":"Hum Vaccines Immunother"},{"key":"5862_CR41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2352-4642(18)30103-2","volume":"2","author":"P Bryan","year":"2018","unstructured":"Bryan P, Seabroke S, Wong J, Donegan K, Webb E, Goldsmith C, Vipond C, Feavers I (2018) Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study. Lancet Child Adolesc Health 2:395\u2013403","journal-title":"Lancet Child Adolesc Health"},{"key":"5862_CR42","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","volume":"388","author":"SR Parikh","year":"2016","unstructured":"Parikh SR, Andrews NJ, Beebeejaun K, Campbell H, Ribeiro S, Ward C, White JM, Borrow R, Ramsay ME, Ladhani SN (2016) Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study. Lancet 388:2775\u20132782","journal-title":"Lancet"},{"key":"5862_CR43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/20477724.2016.1195072","volume":"110","author":"P Kuhdari","year":"2016","unstructured":"Kuhdari P, Stefanati A, Lupi S, Valente N, Gabutti G (2016) Meningococcal B vaccination: real-world experience and future perspectives. Pathog Glob Health 110:148\u2013156","journal-title":"Pathog Glob Health"},{"key":"5862_CR44","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/S0140-6736(12)60436-X","volume":"379","author":"JB Harris","year":"2012","unstructured":"Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB (2012) Cholera. Lancet 379:2466\u20132476","journal-title":"Lancet"},{"key":"5862_CR45","first-page":"117","volume":"85","author":"World Health Organization","year":"2010","unstructured":"World Health Organization (2010) Cholera vaccines: WHO position paper. Wkly Epidemiol Rec 85:117\u2013128","journal-title":"Wkly Epidemiol Rec"},{"key":"5862_CR46","volume-title":"Ending cholera\u2014a global roadmap to 2030","author":"Global Task Force on Cholera Control","year":"2017","unstructured":"Global Task Force on Cholera Control (2017) Ending cholera\u2014a global roadmap to 2030. World Health Organization, Geneva"},{"key":"5862_CR47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","volume":"366","author":"M Ali","year":"2005","unstructured":"Ali M, Emch M, von Seidlein L, Yunus M, Sack DA, Rao M, Holmgren J, Clemens JD (2005) Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet 366:44\u201349","journal-title":"Lancet"},{"key":"5862_CR48","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1371\/journal.pmed.0040336","volume":"4","author":"IM Longini Jr","year":"2007","unstructured":"Longini IM Jr, Nizam A, Ali M, Yunus M, Shenvi N, Clemens JD (2007) Controlling endemic cholera with oral vaccines. PLoS Med 4:e336","journal-title":"PLoS Med"},{"key":"5862_CR49","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1524-4733.2009.00562.x","volume":"12","author":"M Jeuland","year":"2009","unstructured":"Jeuland M, Cook J, Poulos C, Clemens J, Whittington D (2009) Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis. Value Health 12:899\u2013908","journal-title":"Value Health"},{"key":"5862_CR50","first-page":"229","volume":"411","author":"ES Higgs","year":"2017","unstructured":"Higgs ES, Dubey SA, Coller BAG, Simon JK, Bollinger L, Sorenson RA, Wilson B, Nason MC, Hensley LE (2017) Accelerating vaccine development during the 2013\u20132016 West African Ebola virus disease outbreak. Curr Top Microbiol Immunol 411:229\u2013261","journal-title":"Curr Top Microbiol Immunol"},{"key":"5862_CR51","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","volume":"374","author":"ST Agnandji","year":"2016","unstructured":"Agnandji ST, Huttner A, Zinser ME et al (2016) Phase 1 trials of rVSV Ebola vaccine in Africa and Europe. N Engl J Med 374:1647\u20131660","journal-title":"N Engl J Med"},{"key":"5862_CR52","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","volume":"389","author":"AM Henao-Restrepo","year":"2017","unstructured":"Henao-Restrepo AM, Camacho A, Longini IM et al (2017) Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00e7a suffit!). Lancet 389:505\u2013518","journal-title":"Lancet"},{"key":"5862_CR53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMsr1904253","volume":"381","author":"O Ilunga Kalenga","year":"2019","unstructured":"Ilunga Kalenga O, Moeti M, Sparrow A, Nguyen VK, Lucey D, Ghebreyesus TA (2019) The ongoing Ebola epidemic in the Democratic Republic of Congo, 2018\u20132019. N Engl J Med 381:373\u2013383","journal-title":"N Engl J Med"},{"key":"5862_CR54","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/PCC.0000000000000851","volume":"17","author":"L Straney","year":"2016","unstructured":"Straney L, Schibler A, Ganeshalingham A, Alexander J, Festa M, Slater A, MacLaren G, Schlapbach LJ (2016) Burden and outcomes of severe pertussis infection in critically ill infants. Pediatr Crit Care Med 17:735\u2013742","journal-title":"Pediatr Crit Care Med"},{"key":"5862_CR55","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJMp1209051","volume":"367","author":"JD Cherry","year":"2012","unstructured":"Cherry JD (2012) Epidemic pertussis in 2012\u2014the resurgence of a vaccine-preventable disease. N Engl J Med 367:785\u2013787","journal-title":"N Engl J Med"},{"key":"5862_CR56","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3389\/fimmu.2019.01344","volume":"10","author":"S Esposito","year":"2019","unstructured":"Esposito S, Stefanelli P, Fry NK, Fedele G, He Q, Paterson P, Tan T, Knuf M, Rodrigo C, Weil Olivier C, Flanagan KL, Hung I, Lutsar I, Edwards K, O\u2019Ryan M, Principi N (2019) Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines. Front Immunol 10:1344","journal-title":"Front Immunol"},{"key":"5862_CR57","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.inf.0000258699.64164.6d","volume":"26","author":"AM Wendelboe","year":"2007","unstructured":"Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, Gerber M, Grimprel E, Greenberg D, Halperin S, Liese J, Munoz-Rivas F, Teyssou R, Guiso N, Van Rie A (2007) Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 26:293\u2013299","journal-title":"Pediatr Infect Dis J"},{"key":"5862_CR58","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1080\/14767058.2017.1406475","volume":"32","author":"M Lumbreras Areta","year":"2019","unstructured":"Lumbreras Areta M, Eberhardt CS, Siegrist CA, Martinez de Tejada B (2019) Antenatal vaccination to decrease pertussis in infants: safety, effectiveness, timing, and implementation. J Matern Fetal Neonatal Med 32:1541\u20131546","journal-title":"J Matern Fetal Neonatal Med"},{"key":"5862_CR59","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/cid\/ciw027","volume":"62","author":"CS Eberhardt","year":"2016","unstructured":"Eberhardt CS, Blanchard-Rohner G, Lemaitre B, Boukrid M, Combescure C, Othenin-Girard V, Chilin A, Petre J, de Tejada BM, Siegrist CA (2016) Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis. Clin Infect Dis 62:829\u2013836","journal-title":"Clin Infect Dis"},{"key":"5862_CR60","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/cid\/cix046","volume":"64","author":"CS Eberhardt","year":"2017","unstructured":"Eberhardt CS, Blanchard-Rohner G, Lemaitre B, Combescure C, Othenin-Girard V, Chilin A, Petre J, Martinez de Tejada B, Siegrist CA (2017) Pertussis antibody transfer to preterm neonates after second- versus third-trimester maternal immunization. Clin Infect Dis 64:1129\u20131132","journal-title":"Clin Infect Dis"},{"key":"5862_CR61","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1093\/cid\/ciw530","volume":"63","author":"A Sobanjo-Ter Meulen","year":"2016","unstructured":"Sobanjo-Ter Meulen A, Duclos P, McIntyre P, Lewis KD, Van Damme P, O\u2019Brien KL, Klugman KP (2016) Assessing the evidence for maternal pertussis immunization: a report from the Bill & Melinda Gates foundation symposium on pertussis infant disease burden in low- and lower-middle-income countries. Clin Infect Dis 63:S123\u2013S133","journal-title":"Clin Infect Dis"},{"key":"5862_CR62","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barbera J, Vesikari T, Watanabe D, Weckx L, Zahaf T, Heineman TC, Group ZOES (2015) Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 372:2087\u20132096","journal-title":"N Engl J Med"},{"key":"5862_CR63","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham AL, Lal H, Kovac M et al (2016) Efficacy of the herpes zoster subunit vaccine in adults 70\u00a0years of age or older. N Engl J Med 375:1019\u20131032","journal-title":"N Engl J Med"},{"key":"5862_CR64","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.mayocp.2015.09.006","volume":"90","author":"RM Jacobson","year":"2015","unstructured":"Jacobson RM, St Sauver JL, Finney Rutten LJ (2015) Vaccine hesitancy. Mayo Clin Proc 90:1562\u20131568","journal-title":"Mayo Clin Proc"},{"key":"5862_CR65","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1086\/377712","volume":"189","author":"RT Perry","year":"2004","unstructured":"Perry RT, Halsey NA (2004) The clinical significance of measles: a review. J Infect Dis 189:S4\u2013S16","journal-title":"J Infect Dis"},{"key":"5862_CR66","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.1992.03480090085032","volume":"267","author":"LJ Kaplan","year":"1992","unstructured":"Kaplan LJ, Daum RS, Smaron M, McCarthy CA (1992) Severe measles in immunocompromised patients. JAMA 267:1237\u20131241","journal-title":"JAMA"},{"key":"5862_CR67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(10)62352-5","volume":"379","author":"WJ Moss","year":"2012","unstructured":"Moss WJ, Griffin DE (2012) Measles. Lancet 379:153\u2013164","journal-title":"Lancet"},{"key":"5862_CR68","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00430-010-0152-3","volume":"199","author":"E Avota","year":"2010","unstructured":"Avota E, Gassert E, Schneider-Schaulies S (2010) Measles virus-induced immunosuppression: from effectors to mechanisms. Med Microbiol Immunol 199:227\u2013237","journal-title":"Med Microbiol Immunol"},{"key":"5862_CR69","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI13603","volume":"111","author":"MK Slifka","year":"2003","unstructured":"Slifka MK, Homann D, Tishon A, Pagarigan R, Oldstone MB (2003) Measles virus infection results in suppression of both innate and adaptive immune responses to secondary bacterial infection. J Clin Investig 111:805\u2013810","journal-title":"J Clin Investig"},{"key":"5862_CR70","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1136\/bmj.39058.361620.BE","volume":"333","author":"NA Halsey","year":"2006","unstructured":"Halsey NA (2006) Measles in developing countries. BMJ 333:1234","journal-title":"BMJ"},{"key":"5862_CR71","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/oxfordjournals.aje.a010145","volume":"151","author":"G De Serres","year":"2000","unstructured":"De Serres G, Gay NJ, Farrington CP (2000) Epidemiology of transmissible diseases after elimination. Am J Epidemiol 151:1039\u20131052","journal-title":"Am J Epidemiol"},{"key":"5862_CR72","doi-asserted-by":"crossref","first-page":"i20998","DOI":"10.2807\/1560-7917.ES2015.20.1.20998","volume":"20","author":"N Hens","year":"2015","unstructured":"Hens N, Abrams S, Santermans E, Theeten H, Goeyvaerts N, Lernout T, Leuridan E, Van Kerckhove K, Goossens H, Van Damme P, Beutels P (2015) Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013. Euro Surveill 20:i20998","journal-title":"Euro Surveill"},{"key":"5862_CR73","doi-asserted-by":"crossref","first-page":"402","DOI":"10.15585\/mmwr.mm6817e1","volume":"68","author":"M Patel","year":"2019","unstructured":"Patel M, Lee AD, Redd SB, Clemmons NS, McNall RJ, Cohn AC, Gastanaduy PA (2019) Increase in measles cases\u2014United States, January 1\u2013April 26, 2019. MMWR Morb Mortal Wkly Rep 68:402\u2013404","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5862_CR74","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jama.2016.1353","volume":"315","author":"VK Phadke","year":"2016","unstructured":"Phadke VK, Bednarczyk RA, Salmon DA, Omer SB (2016) Association between vaccine refusal and vaccine-preventable diseases in the United States: a review of measles and pertussis. JAMA 315:1149\u20131158","journal-title":"JAMA"},{"key":"5862_CR75","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jamapediatrics.2017.1695","volume":"171","author":"NC Lo","year":"2017","unstructured":"Lo NC, Hotez PJ (2017) Public health and economic consequences of vaccine hesitancy for measles in the United States. JAMA Pediatr 171:887\u2013892","journal-title":"JAMA Pediatr"},{"key":"5862_CR76","first-page":"199","volume":"345","author":"M Iizuka","year":"1995","unstructured":"Iizuka M, Nakagomi O, Chiba M, Ueda S, Masamune O (1995) Absence of measles virus in Crohn\u2019s disease. Lancet 345:199","journal-title":"Lancet"},{"key":"5862_CR77","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/bmj.324.7334.393","volume":"324","author":"B Taylor","year":"2002","unstructured":"Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J (2002) Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 324:393\u2013396","journal-title":"BMJ"},{"key":"5862_CR78","doi-asserted-by":"crossref","first-page":"c5347","DOI":"10.1136\/bmj.c5347","volume":"342","author":"B Deer","year":"2011","unstructured":"Deer B (2011) How the case against the MMR vaccine was fixed. BMJ 342:c5347","journal-title":"BMJ"},{"key":"5862_CR79","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(10)60175-4","volume":"375","author":"Editors of The Lancet","year":"2010","unstructured":"Editors of The Lancet (2010) Retraction: ileal lymphoid nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 375:445","journal-title":"Lancet"},{"key":"5862_CR80","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/B978-0-323-35761-6.00037-7","volume-title":"Plotkin\u2019s vaccines","author":"PM Strebel","year":"2018","unstructured":"Strebel PM, Papania MJ, Gasta\u00f1aduy PA, Goodson JL (2018) Measles vaccines. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM (eds) Plotkin\u2019s vaccines. Elsevier, Philadelphia, pp 579\u2013618"},{"key":"5862_CR81","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/B978-0-323-35761-6.00031-6","volume-title":"Plotkin\u2019s vaccines","author":"J Bresee","year":"2018","unstructured":"Bresee J, Fry AM, Sambhara S, Cox NJ (2018) Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM (eds) Plotkin\u2019s vaccines. Elsevier, Philadelphia, pp 456\u2013488"},{"key":"5862_CR82","volume-title":"Global influenza strategy 2019\u20132030","author":"World Health Organization","year":"2019","unstructured":"World Health Organization (2019) Global influenza strategy 2019\u20132030. World Health Organization, Geneva"},{"key":"5862_CR83","doi-asserted-by":"crossref","first-page":"100036","DOI":"10.1016\/j.jvacx.2019.100036","volume":"2","author":"DC Jenkin","year":"2019","unstructured":"Jenkin DC, Mahgoub H, Morales KF, Lambach P, Nguyen-Van-Tam JS (2019) A rapid evidence appraisal of influenza vaccination in health workers: an important policy in an area of imperfect evidence. Vaccine X 2:100036","journal-title":"Vaccine X"},{"key":"5862_CR84","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/21645515.2017.1348442","volume":"14","author":"G Dini","year":"2018","unstructured":"Dini G, Toletone A, Sticchi L, Orsi A, Bragazzi NL, Durando P (2018) Influenza vaccination in healthcare workers: a comprehensive critical appraisal of the literature. Hum Vaccines Immunother 14:772\u2013789","journal-title":"Hum Vaccines Immunother"},{"key":"5862_CR85","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhin.2016.07.003","volume":"94","author":"KW To","year":"2016","unstructured":"To KW, Lai A, Lee KC, Koh D, Lee SS (2016) Increasing the coverage of influenza vaccination in healthcare workers: review of challenges and solutions. J Hosp Infect 94:133\u2013142","journal-title":"J Hosp Infect"},{"key":"5862_CR86","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.vaccine.2012.10.089","volume":"31","author":"M Miles","year":"2013","unstructured":"Miles M, Ryman TK, Dietz V, Zell E, Luman ET (2013) Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature. Vaccine 31:1560\u20131568","journal-title":"Vaccine"},{"key":"5862_CR87","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1080\/21645515.2015.1074358","volume":"11","author":"A Gagneur","year":"2015","unstructured":"Gagneur A, Pinquier D, Quach C (2015) Immunization of preterm infants. Hum Vaccines Immunother 11:2556\u20132563","journal-title":"Hum Vaccines Immunother"},{"key":"5862_CR88","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1111\/jocn.13916","volume":"26","author":"H Sisson","year":"2017","unstructured":"Sisson H, Gardiner E, Watson R (2017) Vaccination timeliness in preterm infants: an integrative review of the literature. J Clin Nurs 26:4094\u20134104","journal-title":"J Clin Nurs"},{"key":"5862_CR89","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","volume":"58","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, Kang I (2014) 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 58:309\u2013318","journal-title":"Clin Infect Dis"},{"key":"5862_CR90","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13:862\u2013874","journal-title":"Nat Rev Immunol"},{"key":"5862_CR91","doi-asserted-by":"crossref","first-page":"e98960","DOI":"10.1172\/jci.insight.98960","volume":"3","author":"B Francois","year":"2018","unstructured":"Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, Monneret G, Rimmele T, Blood T, Morre M, Gregoire A, Mayo GA, Blood J, Durum SK, Sherwood ER, Hotchkiss RS (2018) Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight 3:e98960","journal-title":"JCI Insight"},{"key":"5862_CR92","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4049\/jimmunol.1701618","volume":"200","author":"IJ Jensen","year":"2018","unstructured":"Jensen IJ, Sjaastad FV, Griffith TS, Badovinac VP (2018) Sepsis-induced T cell immunoparalysis: the ins and outs of impaired T cell immunity. J Immunol 200:1543\u20131553","journal-title":"J Immunol"},{"key":"5862_CR93","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3389\/fimmu.2018.02532","volume":"9","author":"FV Sjaastad","year":"2018","unstructured":"Sjaastad FV, Condotta SA, Kotov JA, Pape KA, Dail C, Danahy DB, Kucaba TA, Tygrett LT, Murphy KA, Cabrera-Perez J, Waldschmidt TJ, Badovinac VP, Griffith TS (2018) Polymicrobial sepsis chronic immunoparalysis is defined by diminished ag-specific T cell-dependent B cell responses. Front Immunol 9:2532","journal-title":"Front Immunol"},{"key":"5862_CR94","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/1744666X.2019.1562336","volume":"15","author":"N Bruse","year":"2019","unstructured":"Bruse N, Leijte GP, Pickkers P, Kox M (2019) New frontiers in precision medicine for sepsis-induced immunoparalysis. Expert Rev Clin Immunol 15:251\u2013263","journal-title":"Expert Rev Clin Immunol"},{"key":"5862_CR95","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(14)60844-8","volume":"384","author":"CJ Murray","year":"2014","unstructured":"Murray CJ, Ortblad KF, Guinovart C et al (2014) Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384:1005\u20131070","journal-title":"Lancet"},{"key":"5862_CR96","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095\u20132128","journal-title":"Lancet"},{"key":"5862_CR97","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/MCC.0000000000000338","volume":"22","author":"MW Pletz","year":"2016","unstructured":"Pletz MW, Uebele J, Gotz K, Hagel S, Bekeredjian-Ding I (2016) Vaccines against major ICU pathogens: where do we stand? Curr Opin Crit Care 22:470\u2013476","journal-title":"Curr Opin Crit Care"},{"key":"5862_CR98","doi-asserted-by":"crossref","first-page":"12896","DOI":"10.1073\/pnas.1721095115","volume":"115","author":"KP Klugman","year":"2018","unstructured":"Klugman KP, Black S (2018) Impact of existing vaccines in reducing antibiotic resistance: primary and secondary effects. Proc Natl Acad Sci USA 115:12896\u201312901","journal-title":"Proc Natl Acad Sci USA"},{"key":"5862_CR99","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/14760584.2019.1639502","volume":"18","author":"A Bechini","year":"2019","unstructured":"Bechini A, Boccalini S, Ninci A, Zanobini P, Sartor G, Bonaccorsi G, Grazzini M, Bonanni P (2019) Childhood vaccination coverage in Europe: impact of different public health policies. Expert Rev Vaccines 18:693\u2013701","journal-title":"Expert Rev Vaccines"},{"key":"5862_CR100","doi-asserted-by":"crossref","first-page":"1900376","DOI":"10.2807\/1560-7917.ES.2019.24.26.1900376","volume":"24","author":"H Holzmann","year":"2019","unstructured":"Holzmann H, Wiedermann U (2019) Mandatory vaccination: suited to enhance vaccination coverage in Europe? Euro Surveill 24:1900376","journal-title":"Euro Surveill"},{"key":"5862_CR101","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00006454-199902000-00002","volume":"18","author":"M Radetsky","year":"1999","unstructured":"Radetsky M (1999) Smallpox: a history of its rise and fall. Pediatr Infect Dis J 18:85\u201393","journal-title":"Pediatr Infect Dis J"},{"key":"5862_CR102","volume-title":"Plotkin\u2019s vaccines","author":"SA Plotkin","year":"2018","unstructured":"Plotkin SA, Orenstein WA, Offit PA, Edwards KM (2018) Plotkin\u2019s vaccines. Elsevier, Philadelphia"},{"key":"5862_CR103","first-page":"Cd000974","volume":"8","author":"PM Graves","year":"2010","unstructured":"Graves PM, Deeks JJ, Demicheli V, Jefferson T (2010) Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected). Cochrane Database Syst Rev 8:Cd000974","journal-title":"Cochrane Database Syst Rev"},{"key":"5862_CR104","first-page":"Cd008603","volume":"3","author":"D Sinclair","year":"2011","unstructured":"Sinclair D, Abba K, Zaman K, Qadri F, Graves PM (2011) Oral vaccines for preventing cholera. Cochrane Database Syst Rev 3:Cd008603","journal-title":"Cochrane Database Syst Rev"},{"key":"5862_CR105","first-page":"Cd001261","volume":"5","author":"R Milligan","year":"2018","unstructured":"Milligan R, Paul M, Richardson M, Neuberger A (2018) Vaccines for preventing typhoid fever. Cochrane Database Syst Rev 5:Cd001261","journal-title":"Cochrane Database Syst Rev"},{"key":"5862_CR106","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/B978-0-323-35761-6.00043-2","volume-title":"Plotkin\u2019s vaccines","author":"KM Edwards","year":"2018","unstructured":"Edwards KM, Decker MD (2018) Pertussis vaccines. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM (eds) Plotkin\u2019s vaccines. Elsevier, Philadelphia, pp 711\u2013761"},{"key":"5862_CR107","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","volume":"282","author":"C Dye","year":"1999","unstructured":"Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project. JAMA 282:677\u2013686","journal-title":"JAMA"},{"key":"5862_CR108","first-page":"Cd001269","volume":"2","author":"V Demicheli","year":"2018","unstructured":"Demicheli V, Jefferson T, Ferroni E, Rivetti A, Di Pietrantonj C (2018) Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2:Cd001269","journal-title":"Cochrane Database Syst Rev"},{"key":"5862_CR109","first-page":"CD004407","volume":"2","author":"V Demicheli","year":"2012","unstructured":"Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C (2012) Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev 2:CD004407","journal-title":"Cochrane Database Syst Rev"},{"key":"5862_CR110","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/B978-0-323-35761-6.00039-0","volume-title":"Plotkin\u2019s vaccines","author":"SA Rubin","year":"2018","unstructured":"Rubin SA (2018) Mumps vaccines. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM (eds) Plotkin\u2019s vaccines. Elsevier, Philadelphia, pp 663\u2013688"},{"key":"5862_CR111","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/B978-0-323-35761-6.00045-6","volume-title":"Plotkin\u2019s vaccines","author":"KP Klugman","year":"2018","unstructured":"Klugman KP, Dagan R, Malley R, Whitney CG (2018) Pneumococcal conjugate vaccine and pneumococcal common protein vaccines. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM (eds) Plotkin\u2019s vaccines. Elsevier, Philadelphia, pp 773\u2013815"},{"key":"5862_CR112","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/B978-0-323-35761-6.00046-8","volume-title":"Plotkin\u2019s vaccines","author":"JD Grabenstein","year":"2018","unstructured":"Grabenstein JD, Musher DM (2018) Pneumococcal polysaccharide vaccines. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM (eds) Plotkin\u2019s vaccines. Elsevier, Philadelphia, pp 816\u2013840"},{"key":"5862_CR113","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2017.04.004","volume":"146","author":"DM Harper","year":"2017","unstructured":"Harper DM, DeMars LR (2017) HPV vaccines\u2014a review of the first decade. Gynecol Oncol 146:196\u2013204","journal-title":"Gynecol Oncol"},{"key":"5862_CR114","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1080\/21645515.2015.1108500","volume":"12","author":"R Luckett","year":"2016","unstructured":"Luckett R, Feldman S (2016) Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer. Hum Vaccines Immunother 12:1332\u20131342","journal-title":"Hum Vaccines Immunother"},{"key":"5862_CR115","doi-asserted-by":"crossref","first-page":"e13571","DOI":"10.1111\/petr.13571","volume":"23","author":"S Suresh","year":"2019","unstructured":"Suresh S, Upton J, Green M, Pham-Huy A, Posfay-Barbe KM, Michaels MG, Top KA, Avitzur Y, Burton C, Chong PP, Danziger-Isakov L, Dipchand AI, Hebert D, Kumar D, Morris SK, Nalli N, Ng VL, Nicholas SK, Robinson JL, Solomon M, Tapiero B, Verma A, Walter JE, Allen UD (2019) Live vaccines after pediatric solid organ transplant: proceedings of a consensus meeting, 2018. Pediatr Transplant 23:e13571","journal-title":"Pediatr Transplant"},{"key":"5862_CR116","first-page":"243","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","unstructured":"Centers for Disease Control and Prevention (1999) Impact of vaccines universally recommended for children\u2014United States, 1990\u20131998. MMWR Morb Mortal Wkly Rep 48:243\u2013248","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5862_CR117","first-page":"ii-92","volume":"47","author":"Centers for Disease Control and Prevention","year":"1999","unstructured":"Centers for Disease Control and Prevention (1999) Summary of notifiable diseases, United States, 1998. MMWR Morb Mortal Wkly Rep 47:ii-92","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5862_CR118","unstructured":"Centers for Disease Control and Prevention (2019) National notifiable diseases surveillance system, weekly tables of infectious disease data. Atlanta, GA. CDC division of health informatics and surveillance. https:\/\/www.cdc.gov\/nndss\/infectious-tables.html. Accessed 14 Aug 2019"},{"key":"5862_CR119","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0264-410X(94)90315-8","volume":"12","author":"RT Chen","year":"1994","unstructured":"Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA, Wassilak SG (1994) The vaccine adverse event reporting system (VAERS). Vaccine 12:542\u2013550","journal-title":"Vaccine"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-019-05862-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-019-05862-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-019-05862-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T18:26:43Z","timestamp":1744136803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-019-05862-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":119,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["5862"],"URL":"https:\/\/doi.org\/10.1007\/s00134-019-05862-0","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,26]]},"assertion":[{"value":"28 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}